# Ephedrine Versus Ondansetron During Cesarean Delivery

> **NCT05127876** · PHASE4 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 168 (actual)

## Conditions studied

- Spinal Induced Hypotension

## Interventions

- **DRUG:** Ondansetron 4 MG
- **DRUG:** Ondansetron 8mg
- **DRUG:** EPHEDrine 10 Mg/mL-NaCl 0.9% Intravenous Solution
- **OTHER:** 10 mL normal saline

## Key facts

- **NCT ID:** NCT05127876
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-10
- **Primary completion:** 2022-03-01
- **Final completion:** 2022-03-06
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2022-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05127876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05127876, "Ephedrine Versus Ondansetron During Cesarean Delivery". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05127876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*